Related Experiment Video
Updated: Feb 9, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
Mauro Di Bari1, Alessandra Pratesi, Francesca M Nigro
1University of Florence, Department of Experimental and Clinical Medicine. mauro.dibari@unifi.it.
Insights
For older patients with atrial fibrillation (AF) and coronary artery disease needing stenting, triple therapy increases bleeding risk. Alternative treatments show promise for improved safety in this complex patient group.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Atrial fibrillation (AF) and coronary artery disease (CAD) frequently coexist in elderly patients.
- Percutaneous coronary intervention (PCI) with stenting is a common treatment for CAD.
- Concurrent anticoagulation and dual antiplatelet therapy (triple therapy) is often required, posing significant bleeding risks.
Purpose of the Study:
- To review evidence comparing triple therapy with alternative regimens in AF patients undergoing PCI.
- To assess the safety and efficacy of different therapeutic strategies.
Main Methods:
- Systematic review of randomized clinical trials and observational studies.
- Comparison of triple therapy against various alternative treatment options.
- Focus on bleeding risk and therapeutic outcomes.
Main Results:
- Current guidelines recommend triple therapy, particularly in acute coronary syndrome (ACS).
- Triple therapy is associated with an excessive risk of bleeding.
- Alternative regimens to triple therapy demonstrate promising safety profiles.
Conclusions:
- While evidence is not exhaustive, alternative strategies to triple therapy in AF patients undergoing PCI are encouraging.
- Further research is crucial to establish optimal, safer treatment protocols.
- Balancing antithrombotic efficacy and bleeding risk remains a key challenge.
Abstract:
Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recommend triple therapy, especially in the course of acute coronary syndrome (ACS), with limitations due to an excessive risk of bleeding associated with this therapeutic regimen. This review summarizes randomized clinical trials and observational studies that compared triple therapy with a variety of different therapeutic options. Although the available evidence is not completely satisfactory and other studies are urgently needed, alternative regimens to triple therapy in AF patients undergoing PCI and stenting are promising, at least in terms of safety.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
AC Sources
Resistor in an AC Circuit
One-way current through the meter is measured using diodes. A diode is a device with better conductivity in one direction compared to the other; in its ideal state, it has zero resistance in one direction and allows...
Power in an AC Circuit
In a DC circuit, there is no sinusoidal waveform associated with the supply; the voltages and currents are...

